Research progress of potassium-competitive acid blockers in the treatment of Helicobacter pylori
Helicobacter pylori (H. pylori) infection is a primary pathogen responsible for gastrointestinal diseases, including gastritis, peptic ulcer disease, and gastric cancer. Therefore, the eradication of H. pylori is crucial for the prevention and treatment of these conditions. However, the increasing a...
Saved in:
| Main Authors: | Zhaoli Ma, Shiling Wang, Furui Wang, Qian Ren |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2025-12-01
|
| Series: | Annals of Medicine |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/07853890.2025.2544886 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Role of Potassium-Competitive Acid Blockers in Helicobacter pylori Eradication
by: Jong Kyu Park
Published: (2017-03-01) -
Treatment of Helicobacter Pylori – an Overview of Current Strategies of Diagnostic and Treatment
by: Ruxandra BABIUC, et al.
Published: (2021-09-01) -
New Approaches to Therapy of Helicobacter pylori Infection (by the Materials of the Maastricht Consensus-IV, Florence, 2010)
by: A. G. Evdokimova, et al.
Published: (2020-05-01) -
Benefits of Helicobacter pylori Eradication on Extragastric Diseases
by: Tae Jun Kim, et al.
Published: (2021-12-01) -
Relationship between Helicobacter pylori and immune dermatosis
by: Xin-Yan ZHAO, et al.
Published: (2021-12-01)